Ongoing Clinical Trials
This page is often updated with new and upcoming trials for a variety of therapeutic areas. Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. There are several steps and stages of approval in the clinical trials process before a drug or device can be sold in the consumer market, if ever. Learn about our clinical trials & additional resources
| Superficial Basal Cell Carcinoma Study | Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT) | Request Info |
| Squamous Cell Carcinoma Study | A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients With Recurrent Cutaneous Squamous Cell Carcinoma | Request Info |
| Skin Cancer Gene Expression Study | Prospective Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma | Request Info |
| Immunology of Skin Cancer Study | Prospective, Non-Interventional Natural History Study of Tumor Tissue, Molecular and Cellular Tumor and Immune Biomarkers in High Risk Resectable Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC) | Request Info |
| Non-Invasive Rapid Imaging of Skin Cancer Study | Non-linear microscopy for the rapid processing of Mohs surgery specimens to reduce processing time and improve accuracy | Request Info |
| Under Eye Hollow Study | A Randomized, Evaluator-blinded, Parallel Group, No-treatment Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of Restylane-L® for Correction of Infraorbital Hollows | Closed to Enrollment |
| Crow’s Feet Study | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines | Closed to Enrollment |
Frequently Asked Questions
Study participants will receive study medication and study-related exams at no cost. Compensation for time and travel may be available.